Lipomatous Neoplasms of Soft Tissue: A Contemporary Review.

Journal

Advances in anatomic pathology

ISSN: 1533-4031

Titre abrégé: Adv Anat Pathol

Pays: United States

ID NLM: 9435676

Informations de publication

Date de publication:
22 Oct 2024

Historique:

medline: 22 10 2024

pubmed: 22 10 2024

entrez: 22 10 2024

Statut: aheadofprint

Résumé

This review summarizes the clinicopathologic features of various lipomatous tumors of soft tissue and addresses some recent conceptual issues relating to adipocytic neoplasms, such as atypical spindle cell/pleomorphic lipomatous tumor and myxoid pleomorphic liposarcoma, and provides an update on the molecular aspects of these tumors. Recent advances in cytogenetic characterization and classification of lipomatous tumors are reviewed, and the genetic importance of distinct chromosomal aberrations are briefly discussed.

Identifiants

DOI: 10.1097/PAP.0000000000000468 PMID: 39434553

pubmed: 39434553

doi: 10.1097/PAP.0000000000000468

pii: 00125480-990000000-00123

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Déclaration de conflit d'intérêts

The authors have no funding or conflicts of interest to disclose.

Références

WHO Classification of Tumours Editorial Board. WHO Classification of Tumours of Soft Tissue and Bone, 5th ed. Lyon, France: IARC Press; 2020.

Hameed M. Pathology and genetics of adipocytic tumors. Cytogenet Genome Res. 2007;118:138–147.

Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: lipoma. Cancer Genet Cytogenet. 2004;150:93–115.

González-García R, Rodríguez-Campo FJ, Sastre-Pérez J, et al. Benign symmetric lipomatosis (Madelung’s disease): case reports and current management. Aesthetic Plast Surg. 2004;28:108–112; discussion 13.

Zolotov S, Xing C, Mahamid R, et al. Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy. Am J Med Genet A. 2017;173:190–194.

Bartuma H, Domanski HA, Von Steyern FV, et al. Cytogenetic and molecular cytogenetic findings in lipoblastoma. Cancer Genet Cytogenet. 2008;183:60–63.

Gisselsson D, Hibbard MK, Dal Cin P, et al. PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms. Am J Pathol. 2001;159:955–962.

Scapa JV, Cloutier JM, Raghavan SS, et al. DDIT3 immunohistochemistry is a useful tool for the diagnosis of myxoid liposarcoma. Am J Surg Pathol. 2021;45:230–239.

Hunt SJ, Santa Cruz DJ, Barr RJ. Cellular angiolipoma. Am J Surg Pathol. 1990;14:75–81.

Mandahl N, Höglund M, Mertens F, et al. Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer. 1994;9:207–215.

Hisaoka M, Sheng WQ, Tanaka A, et al. HMGIC alterations in smooth muscle tumors of soft tissues and other sites. Cancer Genet Cytogenet. 2002;138:50–55.

Panagopoulos I, Gorunova L, Agostini A, et al. Fusion of the HMGA2 and C9orf92 genes in myolipoma with t(9;12)(p22;q14). Diagn Pathol. 2016;11:22.

Ballaux F, Debiec-Rychter M, De Wever I, et al. Chondroid lipoma is characterized by t(11;16)(q13;p12-13). Virchows Arch. 2004;444:208–210.

Gisselsson D, Domanski HA, Höglund M, et al. Unique cytological features and chromosome aberrations in chondroid lipoma: a case report based on fine-needle aspiration cytology, histopathology, electron microscopy, chromosome banding, and molecular cytogenetics. Am J Surg Pathol. 1999;23:1300–1304.

Huang D, Sumegi J, Dal Cin P, et al. C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma. Genes Chromosomes Cancer. 2010;49:810–818.

Billings SD, Folpe AL. Diagnostically challenging spindle cell lipomas: a report of 34 “low-fat” and “fat-free” variants. Am J Dermatopathol. 2007;29:437–442.

Dal Cin P, Sciot R, Polito P, et al. Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas. Histopathology. 1997;31:222–225.

Libbrecht S, Van Dorpe J, Creytens D. The rapidly expanding group of RB1-deleted soft tissue tumors: an updated review. Diagnostics (Basel). 2021;11:430.

Pauwels P, Sciot R, Croiset F, et al. Myofibroblastoma of the breast: genetic link with spindle cell lipoma. J Pathol. 2000;191:282–285.

Kouhsari LM, LeBoit PE, McCalmont TH, et al. Histopathologic and genetic findings in atypical spindle cell/pleomorphic lipomatous tumors and atypical pleomorphic fibromas. J Cutan Pathol. 2022;49:623–631.

Lecoutere E, Creytens D. Atypical spindle cell/pleomorphic lipomatous tumor. Histol Histopathol. 2020;35:769–778.

Schaefer IM, Fletcher CDM. Recent advances in the diagnosis of soft tissue tumours. Pathology. 2018;50:37–48.

Chirieac LR, Dekmezian RH, Ayala AG. Characterization of the myxoid variant of hibernoma. Ann Diagn Pathol. 2006;10:104–106.

Fletcher CD, Akerman M, Dal Cin P, et al. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol. 1996;148:623–630.

Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol. 2001;25:809–814.

Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31–37.

Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24–30.

Argani P, Facchetti F, Inghirami G, et al. Lymphocyte-rich well-differentiated liposarcoma: report of nine cases. Am J Surg Pathol. 1997;21:884–895.

Binh MB, Sastre-Garau X, Guillou L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29:1340–1347.

Folpe AL, Weiss SW. Lipoleiomyosarcoma (well-differentiated liposarcoma with leiomyosarcomatous differentiation): a clinicopathologic study of nine cases including one with dedifferentiation. Am J Surg Pathol. 2002;26:742–749.

Kulkarni AS, Wojcik JB, Chougule A, et al. MDM2 RNA In situ hybridization for the diagnosis of atypical lipomatous tumor: a study evaluating DNA, RNA, and protein expression. Am J Surg Pathol. 2019;43:446–454.

Montgomery E, Fisher C. Paratesticular liposarcoma: a clinicopathologic study. Am J Surg Pathol. 2003;27:40–47.

Elgar F, Goldblum JR. Well-differentiated liposarcoma of the retroperitoneum: a clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation. Mod Pathol. 1997;10:113–120.

Henricks WH, Chu YC, Goldblum JR, et al. Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol. 1997;21:271–281.

Evans HL, Khurana KK, Kemp BL, et al. Heterologous elements in the dedifferentiated component of dedifferentiated liposarcoma. Am J Surg Pathol. 1994;18:1150–1157.

McCormick D, Mentzel T, Beham A, et al. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas. Am J Surg Pathol. 1994;18:1213–1223.

Engström K, Willén H, Kåbjörn-Gustafsson C, et al. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells. Am J Pathol. 2006;168:1642–1653.

Fiore M, Grosso F, Lo Vullo S, et al. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution. Cancer. 2007;109:2522–2531.

Tallini G, Akerman M, Dal Cin P, et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing, (a report from the CHAMP Group). Am J Surg Pathol. 1996;20:1047–1055.

Hornick JL, Bosenberg MW, Mentzel T, et al. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol. 2004;28:1257–1267.

Huang HY, Antonescu CR. Epithelioid variant of pleomorphic liposarcoma: a comparative immunohistochemical and ultrastructural analysis of six cases with emphasis on overlapping features with epithelial malignancies. Ultrastruct Pathol. 2002;26:299–308.

Creytens D, Folpe AL, Koelsche C, et al. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma. Mod Pathol. 2021;34:2043–2049.